Recalls / Brands / Xultophy 100/3.6
Xultophy 100/3.6
1 FDA drug recall involving brand “Xultophy 100/3.6” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-22 | Class I | Xultophy 100/3.6 (insulin degludec and liraglutide injection), 100 units/mL and 3.6 mg/mL, 3 mL Prefilled Pen, | Novo Nordisk Inc |